J&J beats quarterly expectations on drug sales surge, shares jump
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Johnson & Johnson (JNJ) Taps Session High, Up 4.5%
July 17, 2018 10:33 AM EDTJohnson & Johnson (NYSE: JNJ) Taps Session High, Up 4.5%
... MoreJohnson & Johnson (JNJ) Reverses Pre-Market Decline, Up 0.75% After initially Falling 2.6% Following Q2 Results
July 17, 2018 7:19 AM EDTJohnson & Johnson (NYSE: JNJ) Reverses Pre-Market Decline, Up 0.75% After initially Falling 2.6% Following Q2 Results
